Lamine Bouamrane
Affiliations: | UTSA |
Area:
DopamineGoogle:
"Lamine Bouamrane"Mean distance: (not calculated yet)
Parents
Sign in to add mentorPascale Chavis | grad student | 2011-2015 | Institut de neurobiologie de la méditerranée (INMED) |
Olivier J. Manzoni | grad student | 2011-2015 | Institut de neurobiologie de la méditerranée (INMED) |
Carlos Paladini | post-doc | 2016-2019 | UTSA |
Charles Wilson | post-doc | 2016-2019 | UTSA |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bouamrane L, Scheyer AF, Lassalle O, et al. (2016) Reelin-Haploinsufficiency Disrupts the Developmental Trajectory of the E/I Balance in the Prefrontal Cortex. Frontiers in Cellular Neuroscience. 10: 308 |
Iafrati J, Malvache A, Gonzalez Campo C, et al. (2016) Multivariate synaptic and behavioral profiling reveals new developmental endophenotypes in the prefrontal cortex. Scientific Reports. 6: 35504 |
Chavis P, Iafrati J, Orejarena M, et al. (2015) S.24.02 Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives prefrontal cortex development via the mTOR pathway European Neuropsychopharmacology. 25: S146 |
Iafrati J, Orejarena MJ, Lassalle O, et al. (2014) Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway Molecular Psychiatry. 19: 417-426 |
Beguin S, Crépel V, Aniksztejn L, et al. (2013) An epilepsy-related ARX polyalanine expansion modifies glutamatergic neurons excitability and morphology without affecting GABAergic neurons development. Cerebral Cortex (New York, N.Y. : 1991). 23: 1484-94 |
Iafrati J, Orejarena MJ, Lassalle O, et al. (2013) Erratum: Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway Molecular Psychiatry. 19: 527-527 |